Tri Chemical Laboratories Inc.(JP:4369)
Â¥2,681.00-174.00 (-6.09%)
JP:4369
Tri Chemical Laboratories Inc. financials statements
Â¥2,681.00
At close:-174.00 (-6.09%)
Want to see JP:4369 full AI Analyst Report?
Tri Chemical Laboratories Inc. (4369) Ratios
1 Followers
Tri Chemical Laboratories Inc. Ratios
JP:4369's free cash flow for Q2 2026 was ¥2.55B. For the 2026 fiscal year, JP:4369's free cash flow was decreased by ¥-549.41M and operating cash flow was ¥3.10B. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.06 | 5.13 | 7.44 | 5.15 | 4.15 |
| Quick Ratio | 2.02 | 3.70 | 5.87 | 4.40 | 3.53 |
| Cash Ratio | 0.96 | 2.26 | 4.11 | 3.03 | 2.32 |
| Solvency Ratio | 0.67 | 1.14 | 0.88 | 0.97 | 0.73 |
| Operating Cash Flow Ratio | 0.50 | 0.88 | 1.16 | 1.74 | 1.05 |
| Short-Term Operating Cash Flow Coverage | 4.97 | 5.63 | 4.25 | 8.14 | 3.78 |
| Net Current Asset Value | ¥ 12.13B | ¥ 15.91B | ¥ 14.71B | ¥ 12.68B | ¥ 7.42B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.05 | 0.08 | 0.10 | 0.15 |
| Debt-to-Equity Ratio | 0.11 | 0.06 | 0.09 | 0.13 | 0.20 |
| Debt-to-Capital Ratio | 0.10 | 0.05 | 0.08 | 0.11 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.02 | 0.04 | 0.07 | 0.11 |
| Financial Leverage Ratio | 1.31 | 1.18 | 1.16 | 1.24 | 1.33 |
| Debt Service Coverage Ratio | 6.84 | 7.40 | 5.25 | 7.46 | 5.18 |
| Interest Coverage Ratio | 39.21 | 221.48 | 82.07 | 123.24 | 93.10 |
| Debt to Market Cap | 0.04 | 0.01 | 0.02 | 0.04 | 0.04 |
| Interest Debt Per Share | 131.60 | 55.45 | 74.60 | 100.73 | 133.13 |
| Net Debt to EBITDA | -0.40 | -1.16 | -1.76 | -1.06 | -0.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.76% | 42.04% | 36.33% | 40.42% | 41.77% |
| EBIT Margin | 24.71% | 27.80% | 29.35% | 45.02% | 46.02% |
| EBITDA Margin | 32.74% | 35.06% | 40.95% | 53.79% | 54.83% |
| Operating Profit Margin | 24.71% | 27.80% | 17.32% | 25.39% | 25.71% |
| Pretax Profit Margin | 29.69% | 34.82% | 29.14% | 44.82% | 45.75% |
| Net Profit Margin | 23.09% | 26.25% | 21.97% | 35.01% | 35.38% |
| Continuous Operations Profit Margin | 23.09% | 26.25% | 21.97% | 35.01% | 35.38% |
| Net Income Per EBT | 77.79% | 75.37% | 75.40% | 78.11% | 77.34% |
| EBT Per EBIT | 120.13% | 125.24% | 168.21% | 176.52% | 177.91% |
| Return on Assets (ROA) | 11.67% | 13.36% | 7.75% | 15.05% | 14.48% |
| Return on Equity (ROE) | 15.26% | 15.71% | 8.96% | 18.68% | 19.21% |
| Return on Capital Employed (ROCE) | 14.88% | 15.95% | 6.65% | 12.32% | 11.99% |
| Return on Invested Capital (ROIC) | 11.35% | 11.75% | 4.88% | 9.34% | 8.90% |
| Return on Tangible Assets | 11.69% | 13.39% | 7.78% | 15.11% | 14.57% |
| Earnings Yield | 5.14% | 4.68% | 2.06% | 6.37% | 4.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.67 | 5.21 | 2.79 | 3.03 | 2.97 |
| Payables Turnover | 7.27 | 11.30 | 20.20 | 7.20 | 10.98 |
| Inventory Turnover | 1.89 | 1.83 | 1.78 | 3.00 | 3.13 |
| Fixed Asset Turnover | 1.39 | 1.73 | 1.21 | 1.65 | 1.44 |
| Asset Turnover | 0.51 | 0.51 | 0.35 | 0.43 | 0.41 |
| Working Capital Turnover Ratio | 1.45 | 1.12 | 0.71 | 1.05 | 1.52 |
| Cash Conversion Cycle | 242.40 | 236.77 | 317.97 | 191.54 | 206.09 |
| Days of Sales Outstanding | 99.48 | 70.03 | 130.97 | 120.62 | 122.87 |
| Days of Inventory Outstanding | 193.15 | 199.05 | 205.07 | 121.60 | 116.46 |
| Days of Payables Outstanding | 50.23 | 32.30 | 18.07 | 50.69 | 33.24 |
| Operating Cycle | 292.63 | 269.07 | 336.04 | 242.23 | 239.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 116.79 | 113.09 | 91.46 | 196.70 | 112.25 |
| Free Cash Flow Per Share | -76.66 | 18.64 | 36.66 | 148.80 | 83.51 |
| Dividend Paid and CapEx Coverage Ratio | 0.51 | 0.91 | 1.08 | 2.90 | 2.49 |
| Capital Expenditure Coverage Ratio | 0.60 | 1.20 | 1.67 | 4.11 | 3.91 |
| Operating Cash Flow Coverage Ratio | 0.92 | 2.07 | 1.24 | 1.97 | 0.85 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.19 | 0.26 | 0.46 | 0.31 |
| Free Cash Flow Yield | -2.32% | 0.57% | 0.99% | 6.38% | 2.72% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.44 | 21.35 | 48.54 | 15.69 | 24.26 |
| Price-to-Sales (P/S) Ratio | 4.49 | 5.60 | 10.66 | 5.49 | 8.58 |
| Price-to-Book (P/B) Ratio | 2.97 | 3.35 | 4.35 | 2.93 | 4.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -43.05 | 174.89 | 100.65 | 15.68 | 36.70 |
| Price-to-Operating Cash Flow Ratio | 28.26 | 28.83 | 40.35 | 11.86 | 27.30 |
| Price-to-Earnings Growth (PEG) Ratio | 1.74 | 0.21 | -0.99 | 0.89 | 1.44 |
| Enterprise Value Multiple | 13.31 | 14.83 | 24.28 | 9.15 | 15.06 |
| Enterprise Value | 104.09B | 98.28B | 111.82B | 67.92B | 95.60B |
| EV to EBITDA | 13.31 | 14.83 | 24.28 | 9.15 | 15.06 |
| EV to Sales | 4.36 | 5.20 | 9.94 | 4.92 | 8.26 |
| EV to Free Cash Flow | -41.78 | 162.24 | 93.85 | 14.05 | 35.32 |
| EV to Operating Cash Flow | 27.43 | 26.74 | 37.62 | 10.63 | 26.27 |
| Tangible Book Value Per Share | 1109.64 | 969.74 | 845.17 | 792.11 | 652.14 |
| Shareholders’ Equity Per Share | 1112.40 | 972.02 | 848.40 | 796.26 | 657.74 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.25 | 0.25 | 0.22 | 0.23 |
| Revenue Per Share | 734.93 | 581.78 | 346.07 | 424.76 | 357.07 |
| Net Income Per Share | 169.72 | 152.69 | 76.03 | 148.70 | 126.33 |
| Tax Burden | 0.78 | 0.75 | 0.75 | 0.78 | 0.77 |
| Interest Burden | 1.20 | 1.25 | 0.99 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.06 | 0.04 | 0.04 |
| SG&A to Revenue | 0.10 | 0.11 | 0.11 | 0.09 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.69 | 0.74 | 1.20 | 1.03 | 0.69 |
Currency in JPY

